IXHL
Incannex Healthcare Inc.
NASDAQ: IXHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.71
+3.44% today
Updated 2026-10-28
Market cap
$32.62M
P/E ratio
—
P/S ratio
84.20x
EPS (TTM)
$-1.66
Dividend yield
—
52W range
$2 – $15
Volume
0.1M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
4.0
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$18.84
+595.20%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.95 — safe zone
+ Free cash flow $3.37M — positive
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.01M | $12000.00 | $86000.00 | $0.00 | $0.00 |
| Net income | $-73.47M | $-18.46M | $-46.88M | $-19.30M | $-6.34M |
| EPS | — | — | — | — | $-1.66 |
| Free cash flow | $-16.65M | $-16.12M | $-12.52M | $-12.88M | $3.37M |
| Profit margin | -7,246.01% | -153,825.00% | -54,517.44% | — | — |
Peer comparison
Smart narrative
Incannex Healthcare Inc. trades at $2.71. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.95, it sits in the safe zone.
Frequently asked questions
What is Incannex Healthcare Inc.'s stock price?
Incannex Healthcare Inc. (IXHL) trades at $2.71, on a P/S of 84.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Incannex Healthcare Inc. overvalued?
Incannex Healthcare Inc. carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Incannex Healthcare Inc. (IXHL)?
The 12-month analyst consensus target is $18.84, about 595.2% above the current $2.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Incannex Healthcare Inc.'s Altman Z-Score is 3.95, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio84.20x
ROE-69.63%
Beta2.82
50D MA$3.27
200D MA$4.47
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—